151 related articles for article (PubMed ID: 36802170)
21. Helix-Stabilized Cell-Penetrating Peptides for Delivery of Antisense Morpholino Oligomers: Relationships among Helicity, Cellular Uptake, and Antisense Activity.
Takada H; Tsuchiya K; Demizu Y
Bioconjug Chem; 2022 Jul; 33(7):1311-1318. PubMed ID: 35737901
[TBL] [Abstract][Full Text] [Related]
22. In Vitro Multiexon Skipping by Antisense PMOs in Dystrophic Dog and Exon 7-Deleted DMD Patient.
Nakamura A; Aoki Y; Tsoumpra M; Yokota T; Takeda S
Methods Mol Biol; 2018; 1828():151-163. PubMed ID: 30171540
[TBL] [Abstract][Full Text] [Related]
23. Cationic phosphorodiamidate morpholino oligomers efficiently prevent growth of Escherichia coli in vitro and in vivo.
Mellbye BL; Weller DD; Hassinger JN; Reeves MD; Lovejoy CE; Iversen PL; Geller BL
J Antimicrob Chemother; 2010 Jan; 65(1):98-106. PubMed ID: 19884121
[TBL] [Abstract][Full Text] [Related]
24. Internal Oligoguanidinium-Based Cellular Transporter Enhances Antisense Efficacy of Morpholinos in In Vitro and Zebrafish Model.
Bhadra J; Pattanayak S; Khan PP; Kundu J; Sinha S
Bioconjug Chem; 2016 Oct; 27(10):2254-2259. PubMed ID: 27625020
[TBL] [Abstract][Full Text] [Related]
25. Fully automated fast-flow synthesis of antisense phosphorodiamidate morpholino oligomers.
Li C; Callahan AJ; Simon MD; Totaro KA; Mijalis AJ; Phadke KS; Zhang G; Hartrampf N; Schissel CK; Zhou M; Zong H; Hanson GJ; Loas A; Pohl NLB; Verhoeven DE; Pentelute BL
Nat Commun; 2021 Jul; 12(1):4396. PubMed ID: 34285203
[TBL] [Abstract][Full Text] [Related]
26. Development of a general methodology for labelling peptide-morpholino oligonucleotide conjugates using alkyne-azide click chemistry.
Shabanpoor F; Gait MJ
Chem Commun (Camb); 2013 Nov; 49(87):10260-2. PubMed ID: 24064913
[TBL] [Abstract][Full Text] [Related]
27. Development and Application of an Ultrasensitive Hybridization-Based ELISA Method for the Determination of Peptide-Conjugated Phosphorodiamidate Morpholino Oligonucleotides.
Burki U; Keane J; Blain A; O'Donovan L; Gait MJ; Laval SH; Straub V
Nucleic Acid Ther; 2015 Oct; 25(5):275-84. PubMed ID: 26176274
[TBL] [Abstract][Full Text] [Related]
28. Antiviral activity of morpholino oligomers designed to block various aspects of Equine arteritis virus amplification in cell culture.
van den Born E; Stein DA; Iversen PL; Snijder EJ
J Gen Virol; 2005 Nov; 86(Pt 11):3081-3090. PubMed ID: 16227231
[TBL] [Abstract][Full Text] [Related]
29. Generation of Protein-Phosphorodiamidate Morpholino Oligomer Conjugates for Efficient Cellular Delivery via Anthrax Protective Antigen.
Palacio-Castañeda V; Brock R; Verdurmen WPR
Methods Mol Biol; 2022; 2434():129-141. PubMed ID: 35213014
[TBL] [Abstract][Full Text] [Related]
30. In Vitro Evaluation of Antisense-Mediated Exon Inclusion for Spinal Muscular Atrophy.
Touznik A; Maruyama R; Yokota T
Methods Mol Biol; 2018; 1828():439-454. PubMed ID: 30171558
[TBL] [Abstract][Full Text] [Related]
31. Aggregation and Disaggregation of Morpholino Oligomers in Solution.
Chow G; Morcos PA; Moulton HM
Methods Mol Biol; 2017; 1565():31-38. PubMed ID: 28364231
[TBL] [Abstract][Full Text] [Related]
32. Arginine-rich peptide conjugation to morpholino oligomers: effects on antisense activity and specificity.
Nelson MH; Stein DA; Kroeker AD; Hatlevig SA; Iversen PL; Moulton HM
Bioconjug Chem; 2005; 16(4):959-66. PubMed ID: 16029037
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of flavivirus infections by antisense oligomers specifically suppressing viral translation and RNA replication.
Deas TS; Binduga-Gajewska I; Tilgner M; Ren P; Stein DA; Moulton HM; Iversen PL; Kauffman EB; Kramer LD; Shi PY
J Virol; 2005 Apr; 79(8):4599-609. PubMed ID: 15795246
[TBL] [Abstract][Full Text] [Related]
34. Development of an efficient method for phosphorodiamidate bond formation by using inorganic salts.
Harakawa T; Tsunoda H; Ohkubo A; Seio K; Sekine M
Bioorg Med Chem Lett; 2012 Feb; 22(3):1445-7. PubMed ID: 22225640
[TBL] [Abstract][Full Text] [Related]
35. Antisense peptide-phosphorodiamidate morpholino oligomer conjugate: dose-response in mice infected with Escherichia coli.
Tilley LD; Mellbye BL; Puckett SE; Iversen PL; Geller BL
J Antimicrob Chemother; 2007 Jan; 59(1):66-73. PubMed ID: 17079242
[TBL] [Abstract][Full Text] [Related]
36. Fmoc-Based Assembly of PNA Oligomers: Manual and Microwave-Assisted Automated Synthesis.
Shaikh AY; Hansen AM; Franzyk H
Methods Mol Biol; 2020; 2105():1-16. PubMed ID: 32088861
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of a Morpholino Nucleic Acid (MNA)-Uridine Phosphoramidite, and Exon Skipping Using MNA/2'-O-Methyl Mixmer Antisense Oligonucleotide.
Chen S; Le BT; Rahimizadeh K; Shaikh K; Mohal N; Veedu RN
Molecules; 2016 Nov; 21(11):. PubMed ID: 27879669
[TBL] [Abstract][Full Text] [Related]
38. Variations in amino acid composition of antisense peptide-phosphorodiamidate morpholino oligomer affect potency against Escherichia coli in vitro and in vivo.
Mellbye BL; Puckett SE; Tilley LD; Iversen PL; Geller BL
Antimicrob Agents Chemother; 2009 Feb; 53(2):525-30. PubMed ID: 19015356
[TBL] [Abstract][Full Text] [Related]
39. Antisense oligonucleotides: absorption, distribution, metabolism, and excretion.
Shadid M; Badawi M; Abulrob A
Expert Opin Drug Metab Toxicol; 2021 Nov; 17(11):1281-1292. PubMed ID: 34643122
[TBL] [Abstract][Full Text] [Related]
40. Solid-phase synthesis of oligoribonucleotides using 9-fluorenylmethoxycarbonyl (Fmoc) for 5'-hydroxyl protection.
Lehmann C; Xu YZ; Christodoulou C; Tan ZK; Gait MJ
Nucleic Acids Res; 1989 Apr; 17(7):2379-90. PubMed ID: 2717397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
